Nilvanstomig
Nilvanstomig (ZG005) is an antibody targeting PD-1 and TIGIT. Nilvanstomig blocks the PD-1/TIGIT pathway, thereby promoting the synergistic activation of T cells and enhancing the anti-tumor activity of NK cells. Nilvanstomig is applicable to relevant research on advanced cervical cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3061475-22-4
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
immunoglobulin (H-gamma4-scFvhk_L-kappa) dimer
Human
PDCD1/PD-1/CD279 & TIGIT
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa-[scFv]2
ELISA, FACS, Functional assay
Chemical Information
-
No. CAS 3061475-22-4
-
SMILES
[Nilvanstomig]
-
Synonyms
ZG005
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)